Non-viral and viral delivery systems for CRISPR-Cas9 technology in the biomedical field

Science China. Life Sciences
Zhi-Yao HeYu-Quan Wei

Abstract

The clustered regularly interspaced short palindromic repeats (CRISPR)-associated protein 9 (CRISPR-Cas9) system provides a novel genome editing technology that can precisely target a genomic site to disrupt or repair a specific gene. Some CRISPR-Cas9 systems from different bacteria or artificial variants have been discovered or constructed by biologists, and Cas9 nucleases and single guide RNAs (sgRNA) are the major components of the CRISPR-Cas9 system. These Cas9 systems have been extensively applied for identifying therapeutic targets, identifying gene functions, generating animal models, and developing gene therapies. Moreover, CRISPR-Cas9 systems have been used to partially or completely alleviate disease symptoms by mutating or correcting related genes. However, the efficient transfer of CRISPR-Cas9 system into cells and target organs remains a challenge that affects the robust and precise genome editing activity. The current review focuses on delivery systems for Cas9 mRNA, Cas9 protein, or vectors encoding the Cas9 gene and corresponding sgRNA. Non-viral delivery of Cas9 appears to help Cas9 maintain its on-target effect and reduce off-target effects, and viral vectors for sgRNA and donor template can improve the effica...Continue Reading

References

Aug 19, 2010·Nature Reviews. Genetics·Fyodor D UrnovPhilip D Gregory
Nov 5, 2010·Nature·Josiane E GarneauSylvain Moineau
Jun 5, 2012·The New England Journal of Medicine·Suzanne L TopalianMario Sznol
Nov 22, 2012·Nature Reviews. Molecular Cell Biology·J Keith Joung, Jeffry D Sander
Jan 5, 2013·Science·Le CongFeng Zhang
Jan 25, 2013·Molecular Therapy. Nucleic Acids·Andrew F AdlerKam W Leong
May 15, 2013·Trends in Biotechnology·Thomas GajCarlos F Barbas
Jul 31, 2013·Nature Methods·Pablo Perez-PineraCharles A Gersbach
Aug 7, 2013·Proceedings of the National Academy of Sciences of the United States of America·Li-En JaoWenbiao Chen
Dec 18, 2013·Science·Ophir ShalemFeng Zhang
Jan 28, 2014·Nature Biotechnology·Yanfang FuJ Keith Joung
Feb 18, 2014·Cell·Hiroshi NishimasuOsamu Nureki
Apr 1, 2014·Nature Biotechnology·Hao YinDaniel G Anderson
Apr 29, 2014·Nature Biotechnology·Shengdar Q TsaiJ Keith Joung
Jul 22, 2014·Microbiology and Immunology·Tadahiro SuenagaHisashi Arase
Aug 20, 2014·Molecular Therapy. Nucleic Acids·Su-Ru LinPei-Jer Chen
Oct 20, 2014·Nature Biotechnology·Lukasz SwiechFeng Zhang
Oct 29, 2014·Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society·Yong FengZhenfeng Duan
Feb 6, 2015·Nature Medicine·David Benjamin Turitz CoxFeng Zhang
Mar 6, 2015·Journal of Virology·Ming YuanYaohe Wang
Apr 2, 2015·Nature·F Ann RanFeng Zhang
Apr 8, 2015·Nature Chemical Biology·Kevin M DavisDavid R Liu
May 20, 2015·Science China. Life Sciences·Hongxin DengYuquan Wei
Jun 16, 2015·Human Gene Therapy·Shaohua YaoChong Chen
Jun 18, 2015·Nucleic Acids Research·Dong-Jiunn Jeffery TruongOskar Ortiz
Jul 29, 2015·Proceedings of the National Academy of Sciences of the United States of America·Kathrin SchumannAlexander Marson
Sep 30, 2015·Molecular Therapy. Methods & Clinical Development·Ming YuanYaohe Wang
Oct 10, 2015·Molecular Therapy : the Journal of the American Society of Gene Therapy·Li XuRenzhi Han
Oct 17, 2015·Translational Research : the Journal of Laboratory and Clinical Medicine·Nataša Savić, Gerald Schwank
Dec 3, 2015·Science·Ian M SlaymakerFeng Zhang
Jan 2, 2016·Science·Mohammadsharif TabebordbarAmy J Wagers

❮ Previous
Next ❯

Citations

Jan 18, 2018·Human Gene Therapy·Zhi-Yao HeYu-Quan Wei
Jun 18, 2019·Journal of Animal Science and Biotechnology·Filipp SavvulidiLudek Stadnik
Jul 10, 2019·Expert Opinion on Drug Delivery·Ah Young LeeSanghwa Kim
Jun 3, 2017·Science China. Life Sciences·Renjie Jiao, Caixia Gao
Sep 10, 2018·Biochemistry. Biokhimii︠a︡·M N KaragyaurV A Tkachuk
Oct 1, 2019·Current Gene Therapy·Ling-Yan ZhouTing Xu
Apr 26, 2019·The CRISPR Journal·Veronica P DuboisJohn A Ronald
Jul 22, 2018·Future Oncology·Diogo EstêvãoRui Medeiros
Dec 10, 2019·Science China. Life Sciences·Lu WenZi-Jiang Chen
Aug 18, 2020·Computational and Structural Biotechnology Journal·Ling-Yan ZhouZhi-Yao He
May 4, 2020·Advanced Drug Delivery Reviews·Xiangrong SongYuquan Wei
Jun 9, 2020·Advanced Drug Delivery Reviews·Michael Y T ChowHak-Kim Chan
Dec 31, 2019·Biotechnology Advances·Cui-Cui MaYu-Quan Wei
Jun 21, 2021·Signal Transduction and Targeted Therapy·Chenya ZhuoMingqiang Li
Aug 9, 2020·Aging and Disease·Allen CaobiNazira El-Hage
Aug 15, 2021·Journal of Controlled Release : Official Journal of the Controlled Release Society·Xiuhua PanXiaole Qi
Aug 22, 2021·Chembiochem : a European Journal of Chemical Biology·Li DuanJiang Xia

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR Ribonucleases Deactivation

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on mechanisms that underlie deactivation of CRISPR ribonucleases. Here is the latest research.

CRISPR (general)

Clustered regularly interspaced short palindromic repeats (CRISPR) are DNA sequences in the genome that are recognized and cleaved by CRISPR-associated proteins (Cas). CRISPR-Cas system enables the editing of genes to create or correct mutations. Discover the latest research on CRISPR here.

CRISPR for Genome Editing

Genome editing technologies enable the editing of genes to create or correct mutations. Clustered regularly interspaced short palindromic repeats (CRISPR) are DNA sequences in the genome that are recognized and cleaved by CRISPR-associated proteins (Cas). Here is the latest research on the use of CRISPR-Cas system in gene editing.

CRISPR Genome Editing & Therapy

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of this system for gene editing and therapy in human diseases.

© 2022 Meta ULC. All rights reserved